Discover why Ideaya Biosciences, Inc. is rated a Buy for its promising oncology pipeline and upcoming catalysts. Click for my ...
Artisan International Small-Mid Fund portfolio underperformed the MSCI ACWI ex USA SMID Index in Q3. Read more here.
Welcome to Senstar Technologies Third Quarter 2025 Results Conference Call. All participants are in a listen-only mode.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback